Repository logo
 

Hippocampal sclerosis, hippocampal neuron loss patterns and Tdp-43 in the aged population

Published version
Peer-reviewed

Type

Article

Change log

Authors

Hokkanen, SRK 
Polvikoski, TM 
Keage, HAD 
Soares Cianciarullo Minett, Thais  ORCID logo  https://orcid.org/0000-0002-3232-9455

Abstract

Hippocampal neuron loss is a common neuropathological feature in old age with various underlying etiologies. Hippocampal sclerosis of aging (HS-Aging) is neuropathologically characterized by severe CA1 neuronal loss and frequent presence of transactive response DNA-binding protein of 43 kDa (TDP-43) aggregations. Its etiology is unclear and currently no standardized approaches to measure HS-Aging exist. We developed a semi-quantitative protocol, which captures various hippocampal neuron loss patterns, and compared their occurrence in the context of HS-Aging, TDP-43, vascular and tau pathology in 672 brains (TDP-43 staining n = 642/672, 96%) donated for the population-based Cambridge City over-75s Cohort and the Cognitive Function and Ageing Study. HS-Aging was first evaluated independently from the protocol using the most common criteria defined in literature, and then described in detail through examination of neuron loss patterns and associated pathologies. 34 (5%) cases were identified, with a maximum of five pyramidal neurons in each of over half CA1 fields-of-view (x200 magnification), no vascular damage, no neuron loss in CA2-CA4, but consistent TDP-43 neuronal solid inclusions and neurites. We also report focal CA1 neuron loss with vascular pathology to affect predominantly CA1 bordering CA2 (Fisher's exact, P = 0.009), whereas neuron loss in the subicular end of CA1 was associated with TDP-43 inclusions (Fisher's exact, P < 0.001) and high Braak stage (Fisher's exact, P = 0.001). Hippocampal neuron loss in CA4-CA2 was not associated with TDP-43. We conclude that hippocampal neuron loss patterns are associated with different etiologies within CA1, and propose that these patterns can be used to form objective criteria for HS-Aging diagnosis. Finally, based on our results we hypothesize that neuron loss leading to HS-Aging starts from the subicular end of CA1 when it is associated with TDP-43 pathology, and that this neurodegenerative process is likely to be significantly more common than “end-stage” HS-Aging only.

Description

Keywords

hippocampus, hippocampal sclerosis, neuron loss, population study, TDP-43

Journal Title

Brain Pathology

Conference Name

Journal ISSN

1015-6305
1750-3639

Volume Title

Publisher

Wiley-Blackwell
Sponsorship
Medical Research Council (G9901400)
Alzheimer's Research UK
Medical Research Council (G0601022)
MRC (1185)
MRC (unknown)
Alzheimer's Research UK (ARUK-PhD2014-19)
Alzheimer's Research UK (ARUK-EG2014B-4)
Medical Research Council (G0601022/1)
The Cambridge Human Research Tissue Bank is supported by the National Institute for Health Research Cambridge Biomedical Research Centre. CFAS is supported by grants (G9901400) from the UK Medical Research Council MRC CFAS was supported in part by: a Special Project grant and a Programme grant from the MRC and the Department of Health; the UK NIHR Biomedical Research Centre for Ageing and Age - related Disease Award to the Newcastle-upon-Tyne Hospitals Foundation Trust; the Cambridge Brain Bank is supported by the NIHR Cambridge Biomedical Research Centre; The Cambridgeshire and Peterborough NIHR CLAHRC; Nottingham University Hospitals NHS Trust; University of Sheffield and the Sheffield Teaching Hospitals NHS Foundation Trust; The Thomas Willis Oxford Brain Collection, supported by the Oxford Biomedical Research Centre; The Walton Centre NHS Foundation Trust, Liverpool. We would like to acknowledge the essential contribution of the liaison officers, the general practitioners, their staff, and nursing and residential home staff. Component projects within CFAS have been support by the Medical Research Council and by the Alzheimer's Research Trust (ART PG2006/6). This project was supported by an Australian NHMRC Project Grant (APP1042889) and The Addenbrooke's Charitable Trust; the later also supported SH. SRKH is supported by an Alzheimer's Research UK scholarship (ARUK-PhD2014–19). HADK is supported by an Australian NHMRC Training Fellowship (GNT568890). FEM is supported by the grant MRC.U.1052.00.013.